Anondita Medicare IPO

Anondita Medicare IPO is a plan to raise funds by issuing 100% book-built or NSE Emerge. A total of up to 47,93,000 fresh equity shares worth ₹10 each will be issued with the IPO. In this offer, all proceeds go to Anondita Medicare Limited. Category allocation follows SME norms, with a maximum of 50% reserved for QIBs, at least 15% NIIs and no more than 35% left for Retail. The proposed application window is 22–26 August 2025, with the listing to be done on the NSE Emerge platform. The company is looking to raise around ₹69.50 crore via this IPO route.

Company Background

Anondita Medicare Limited was incorporated on 12 March 2024 as a public company, after the business had previously run as a sole proprietor under M/s Anondita Healthcare, the Anupam Ghosh-promoted firm. Its registered office is at Vasant Kunj, New Delhi, where it has Operations in Noida (Uttar Pradesh). The company focuses on healthcare consumables for men, with a primary focus on male condoms. In addition, the company has direct technical capacity, regulatory processes and tender registrations through its legacy operations.

Operations & Product Range

Facility & Production

The company manufactures male condoms on automated manufacturing lines. The company’s process begins with compounding through immersing shapes into formers, vulcanizing them, washing, performing electronic tests and applying rubber lubrication. Then it goes into foil packing for safekeeping under medical device/healthcare compliance. Anondita highlights that it now has an installed capacity of 562 million condoms per annum, along with multiple high-speed lines at its Noida plant alone. It will also start production of disposable female condoms, according to the company. All the production conforms to applicable regulations or standards for healthcare consumables and the rubber industry.

Brands & Market Presence

Anondita manufactures and markets male condoms under its flagship brand “Cobra” in various flavours and textures for consumer retail, while also supplying to institutional buyers via tenders and public health programs. The company participates in domestic channels and select export markets and also undertakes private-label manufacturing for third-party brands.

Revenue Channels

• Institutional/government tenders as well as public health programs.
• Export sales to distributors and institutional buyers.
• Domestic sales to retailers, trade buyers and with its brands.
• Private-label as a third-party manufacturer for other brands.

Management & Shareholding

Promoters & Shareholding

The promoters of Anondita Medicare IPO are Mr. Anupam Ghosh, Mrs. Sonia Ghosh and Mr. Reshant Ghosh. The pre-issue promoter holding is around 83.95% and the post-issue of around 61.71%.

Board Members

The board structure follows SME listing norms with executive and independent directors.